2022
DOI: 10.1002/cdt3.11
|View full text |Cite
|
Sign up to set email alerts
|

Cyanobacterial metabolites as novel drug candidates in corona viral therapies: A review

Abstract: Most of the medical and nonmedical research labs, all around the world, are racing against time to produce an effective vaccine or an antiviral medicine for coronavirus disease 2019 (COVID‐19). Conventional medicines and novel nano‐materials including chemical and herbal‐based compounds are all into positive trials toward coronaviruses and other pandemic infections. Among them, natural immune boosters have attracted physicians because of their longevity and reliability for fewer side effects. This is a review … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
5
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(8 citation statements)
references
References 80 publications
0
5
0
Order By: Relevance
“…Additionally, the antiviral medication currently available for these viruses has undesirable side effects. Under these conditions, it is imperative to consider new antiviral possibilities from natural sources, such as unprocessed extracts and cyanobacteria metabolites as discussed (Prabhu et al 2022 ). Hence, the researchers are trying to collect different kind of the compounds such as secondary metabolites from different solvent methods (such as methanol, water, and ethanol) using cyanobacteria to find the novel candidates against the viral diseases with the least side effects and complications in the later stage of the life (Prabhu et al 2022 ).…”
Section: Discussionmentioning
confidence: 99%
“…Additionally, the antiviral medication currently available for these viruses has undesirable side effects. Under these conditions, it is imperative to consider new antiviral possibilities from natural sources, such as unprocessed extracts and cyanobacteria metabolites as discussed (Prabhu et al 2022 ). Hence, the researchers are trying to collect different kind of the compounds such as secondary metabolites from different solvent methods (such as methanol, water, and ethanol) using cyanobacteria to find the novel candidates against the viral diseases with the least side effects and complications in the later stage of the life (Prabhu et al 2022 ).…”
Section: Discussionmentioning
confidence: 99%
“…This valuable software was installed in Centos Linux, which served as the operating system for this docking research. Almost all the methods of computational drug design followed our previous publications (Kalaimathi et al 2021 ; Rani et al 2022 ; Prabhu et al 2022 ).…”
Section: Methodsmentioning
confidence: 99%
“…The diversity of unknown genes identified through ocean surveys (e.g., Sargasso Sea, Tara Oceans) represent the potential for new metabolic processes and biological molecules to be identified (Tara Ocean Foundation, Tara Oceans, European Molecular Biology Laboratory, 2022). Marine microbiomes have already been a source for bioprospecting resulting in the development of an algal-derived nasal spray that is effective against the SARS CoV-2 virus (Figueroa et al, 2021), and metabolites from cyanobacteria are being explored for treating viral infections and skin cancer (Prabhu et al, 2022). Following the initial discovery of the CRISPR/Cas system in bacteria and archaea, the CRISPR-Cas9 genome editing technique has significantly changed how some medical and agricultural research is carried out.…”
Section: Biodiscoverymentioning
confidence: 99%